G2G CONSULTING

Lobbying for CELMATIX · Womens health biotech focused on ovarian biology

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · New York · House · Senate · $10,000.00 income · posted Apr 21, 2025

Lobbying activity 1

Health Issues

Awareness of and funding for ovarian health

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem